John P. Sharp
CIK: 0001342894
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SKYE
Skye Bioscience, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Sharp John P
Sharp John P (SEC CIK 0001342894) files insider reports with the SEC as Chief Financial Officer of Skye Bioscience, Inc. (SKYE).
Signal8 holds 1 ownership filing by Sharp John P, a Form 3, filed on Apr 28, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Sharp John P's filings is in SAN DIEGO, CA.
Other insiders filing for Skye Bioscience, Inc. (SKYE)
- Schwab Andrew J., Director
- 5AM Partners VII, LLC, 10% Owner
- DHILLON PUNIT, Chief Executive Officer
- Smith Karen L., Director
- Twitty Christopher, Chief Scientific Officer
- Jenkins Annalisa, Director